Metagenomic & Metabolomic Study: Bifidobacterium Probiotic Effects on Gut Microbiota & SCFA in Preterm NICU Infants

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
PrematurityLow Birth Weight Neonates
Interventions
DIETARY_SUPPLEMENT

Probiotics

The intervention is giving probiotic supplementation that contains Bifidobacterium longum BB536, Bifidobacterium breve M-16V, Bifidobacterium longum subs.infantis M-63 from Morinaga.

Trial Locations (3)

90152

Hasanuddin University General Hospital, Makassar

90174

Dr. Wahidin Sudirohusodo General Hospital, Makassar

90245

Cahaya Medika General Hospital, Makassar

All Listed Sponsors
lead

Hasanuddin University

OTHER

NCT07213414 - Metagenomic & Metabolomic Study: Bifidobacterium Probiotic Effects on Gut Microbiota & SCFA in Preterm NICU Infants | Biotech Hunter | Biotech Hunter